BioInformant

Your Global Leader in Stem Cell Market Research

Curi Bio and NEXEL Form Celogics, a Joint Venture to Develop iPSC-Derived Products

By Leave a Comment

Celogics, based in Seattle, will offer high-quality iPSC-derived cell products for drug discovery and safety testing.

OCTOBER 26, 2021, SEATTLE and SEOUL – Curi Bio, a global leader in development of human stem cell-based platforms for disease modeling and drug discovery, and NEXEL, a leader in induced pluripotent stem cell (iPSC) technology, today announced the formation of Celogics, a joint venture company focused on the development and commercialization of human iPSC-derived cell products for drug discovery, drug safety testing, and biological research. Celogics iPSC production and distribution headquarters will be located in Seattle, WA. [Read more…]

Therapeutic Solutions Utilizes MSC Exosomes to Suppress Inflammatory Pathologies

By Leave a Comment

  • Therapeutic Solutions International Utilizes Mesenchymal Stem Cell Exosomes to Effectively Suppress Neutrophil Extracellular Trap Production
  • Patent Filed on Potential Solution to Cause of Major Inflammatory Pathologies

ELK CITY, Idaho, Oct. 4, 2021 — Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced laboratory data demonstrating that exosomes produced by JadiCells™, the Company’s Phase III cell therapy candidate for COVID-19 and other lung pathology, as well as mesenchymal stem cells proprietary to the Company, can suppress the production of neutrophil extracellular traps. [Read more…]

Bio-Techne Launches ExCellerate™ iPSC Expansion Medium

By Leave a Comment

A novel animal component-free medium that supports robust expansion and maintenance of human pluripotent stem cells.

Minneapolis, September 14, 2021 — Bio-Techne Corporation (NASDAQ: TECH) Bio-Techne announced the launch of a new medium for the expansion and maintenance of induced pluripotent stem cells (iPSCs) for use in both research and translational workflows. The ExCellerate™ iPSC Expansion Medium is the latest addition to Bio-Techne’s comprehensive portfolio of products and services for Regenerative Medicine. It is designed to fit seamlessly into their offerings for stem cell workflows, including cell isolation, reprogramming, genome engineering, cell expansion, differentiation and characterization. [Read more…]

Shopping cart0
There are no products in the cart!
Continue shopping
0